Juana CBD by Motarebel
Indica-dominant hybrid × Sativa-dominant hybrid
Juana CBD is a hybrid cannabis strain developed by Motarebel, notable for its balanced effects and therapeutic potential. It was bred to merge desirable indica and sativa genetics, aiming for a strain that offers both relaxation and controlled psychoactivity.
Appearance
Juana CBD presents a robust plant structure with dense, compact buds characteristic of indica influence, though subtle sativa traits contribute to a slightly elongated bud shape. The buds are covered in a thick layer of resinous trichomes and often display dark green leaves with hints of purple.
Aroma & Flavor
The aroma of Juana CBD is a complex blend, featuring dominant earthy notes complemented by hints of pine, floral undertones, and a touch of sweetness. Its flavor profile mirrors the aroma, opening with earthiness and citrus, followed by subtle herbal notes and a sweet finish, creating a smooth and balanced taste experience.
Effects
This hybrid strain is reported to induce a sense of calm, offering balanced effects that are neither overwhelmingly sedating nor overly stimulating. It is designed to provide therapeutic benefits with minimal psychoactive intensity, making it suitable for various users.
Terpenes & Cannabinoids
Juana CBD is characterized by a balanced cannabinoid profile, typically featuring low THC levels (around 1-3%) and moderate to high CBD content (ranging from 12-15% in some reports, though the user-provided data states <1% CBD). This composition, along with minor cannabinoids, contributes to its therapeutic properties. Key terpenes identified include Myrcene, Limonene, Caryophyllene, Linalool, and Pinene, which contribute to its distinct aroma and flavor.
Origins & Lineage
Developed by breeder Motarebel, Juana CBD is a hybrid strain intentionally bred to combine the deep relaxation associated with indica genetics and the uplifting creativity of sativa. This lineage was created to offer a balanced experience with therapeutic potential, addressing a market shift towards more medically relevant cannabis options.